Similar articles

• 25-hydroxyvitamin D status does not affect intraoperative parathyroid hormone dynamics in patients with primary hyperparathyroidism.

  Adler JT, Sippel RS, Chen H. Adler JT, et al. Ann Surg Oncol. 2010 Nov;17(11):2958-62. doi: 10.1245/s10434-010-1125-x. Epub 2010 Jun 11. Ann Surg Oncol. 2010. PMID: 20544293
• Impact of 25 hydroxyvitamin D deficiency in perioperative parathyroid hormone kinetics and results in patients with primary hyperparathyroidism.

  Perrier ND. Perrier ND. Surgery. 2007 Dec;142(6):1027-9. doi: 10.1016/j.surg.2007.09.025. Surgery. 2007. PMID: 18063091 No abstract available.
• Normocalcemic primary hyperparathyroidism: a newly emerging disease needing therapeutic intervention.

  Díaz-Soto G, Julián MT, Puig-Domingo M. Díaz-Soto G, et al. Hormones (Athens). 2012 Oct-Dec;11(4):390-6. doi: 10.14310/horm.2002.1370. Hormones (Athens). 2012. PMID: 23422761 Review. No abstract available.
• Associations of serum 25-hydroxyvitamin D with circulating PTH, phosphate and calcium in patients with primary hyperparathyroidism.

  Jayasena CN, Modi M, Palazzo F, De Silva A, Donaldson M, Meeran K, Dhillo WS. Jayasena CN, et al. Clin Endocrinol (Oxf). 2013 Jun;78(6):838-43. doi: 10.1111/cen.12062. Epub 2013 Apr 1. Clin Endocrinol (Oxf). 2013. PMID: 23036072
• Vitamin D deficiency and primary hyperparathyroidism.

  Silverberg SJ. Silverberg SJ. J Bone Miner Res. 2007 Dec;22 Suppl 2:V100-4. doi: 10.1359/jbmr.07s202. J Bone Miner Res. 2007. PMID: 18290710 Review.